Analysts think LSTA stock price could increase by 486%
Feb 11, 2025, 12:25 PM
-11.88%
What does LSTA do
Lisata Therapeutics, based in Basking Ridge, New Jersey, focuses on developing therapies for advanced solid tumors, with its lead candidate LSTA1 enhancing anti-cancer drug penetration in tumors. The company also explores CD34+ cell therapy for various diseases, including critical limb ischemia and diabetic kidney disease.
5 analysts think LSTA stock price will increase by 486.21%. The current median analyst target is $15.30 compared to a current stock price of $2.61. The lowest analysts target is $13.13 and the highest analyst target is $15.75.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
